drugset / Trial / NCT07087197
A Study of SKB107 in Advanced Solid Tumors With Bone Metastases
Non-randomizedSequentialOpen-labelTreatment
Summary
A multicenter, open-label Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, dosimetry and efficacy of SKB107 in subjects with advanced solid tumors with bone metastases.
Timeline
- Start
- 2025-08-15
- Primary completion
- 2027-10-01
- Completion
- 2028-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SKB107 | Unknown | — | — |